受强制性开放获取政策约束的文章 - Dr. Chandramouli Chiruta了解详情
无法在其他位置公开访问的文章：1 篇
A convenient general method for the synthesis of hydroxy diacids
C Chiruta, S Jachak, DLJ Clive
Tetrahedron letters 48 (18), 3141-3143, 2007
强制性开放获取政策： Genome Canada
可在其他位置公开访问的文章：6 篇
The mitochondrial ATP synthase is a shared drug target for aging and dementia
J Goldberg, A Currais, M Prior, W Fischer, C Chiruta, E Ratliff, ...
Aging cell 17 (2), e12715, 2018
强制性开放获取政策： Hewlett Foundation, US National Institutes of Health
A novel neurotrophic drug for cognitive enhancement and Alzheimer's disease
Q Chen, M Prior, R Dargusch, A Roberts, R Riek, C Eichmann, C Chiruta, ...
PloS one 6 (12), e27865, 2011
强制性开放获取政策： US National Institutes of Health
The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice
M Prior, R Dargusch, JL Ehren, C Chiruta, D Schubert
Alzheimer's Research & Therapy 5, 1-19, 2013
强制性开放获取政策： US National Institutes of Health
Back to the future with phenotypic screening
M Prior, C Chiruta, A Currais, J Goldberg, J Ramsey, R Dargusch, ...
ACS Chemical Neuroscience 5 (7), 503-513, 2014
强制性开放获取政策： US National Institutes of Health, National Institute of Health and Medical …
Chemical modification of the multitarget neuroprotective compound fisetin
C Chiruta, D Schubert, R Dargusch, P Maher
Journal of Medicinal Chemistry 55 (1), 378-389, 2012
强制性开放获取政策： US National Institutes of Health
Selecting for neurogenic potential as an alternative for Alzheimer's disease drug discovery
M Prior, J Goldberg, C Chiruta, C Farrokhi, M Kopynets, AJ Roberts, ...
Alzheimer's & Dementia 12 (6), 678-686, 2016
强制性开放获取政策： Hewlett Foundation, US National Institutes of Health
出版信息和资助信息由计算机程序自动确定